Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2011-06-30 06:00:00

MISSISSAUGA, ON, June 30, 2011 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced receipt from Mallinckrodt Inc., a Covidien company (Covidien), of top-line results from a Phase 2 study conducted by Covidien, of twice-daily administration of PENNSAID(®) Viscous Solution (topical diclofenac sodium viscous solution) 2% w/w, previously referred...

2011-06-27 08:00:00

SAN DIEGO, June 27, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel(TM) (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain. The business assets would be acquired in connection with a proposed asset purchase under Section 363 of Chapter 11 of...

2011-06-13 20:19:00

BEDFORD, Ohio, June 13, 2011 /PRNewswire/ -- On April 19, 2011, Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., initiated a nationwide voluntary recall of the following product: (Logo: http://photos.prnewswire.com/prnh/20070809/CLTH157LOGO ) Indomethacin for Injection, USP, 1mg Single Dose Vial NDC #55390-299-01, Lot 1948138, Exp. Date September 2011 PLEASE NOTE: This recall is for Lot 1948138 Only. No other lots of Indomethacin for Injection, USP are subject to...

2011-06-13 08:30:00

MIAMI BEACH, Fla., June 13, 2011 /PRNewswire/ -- Today Divine Skin Inc. (DSKX), a developer of personal-care biotechnology, announced plans to release a new oral analgesic intended to compete over the counter with the likes of Tylenol, Advil, and aspirin. The company plans to begin shipping upon final authorization by the Drug Enforcement Administration. "Since Divine Skin focuses on underserved and niche categories, of course our pain medication will offer patients some benefits that...

2011-05-31 20:40:00

SEOUL, South Korea, May 31, 2011 /PRNewswire/ -- CrystalGenomics, Inc. (Seoul, Korea) and CG Pharmaceuticals, Inc. (Emeryville, California), a biopharmaceutical company with 3 clinical stage candidates, has announced that the first patient has been enrolled for a Phase 2b clinical study of CG100649, CrystalGenomics' clinical stage novel NSAID candidate, in patients with knee or hip osteoarthritis (OA). CG100649 is a first-in-class NSAID drug candidate that is a dual inhibitor of COX-2 and...

2011-05-24 11:37:00

FORT WORTH, Texas, May 24, 2011 /PRNewswire/ -- The family of a child who almost lost her life after taking Children's Motrin has been awarded $10 million by a jury in Philadelphia, Pennsylvania. Thirteen-year-old plaintiff Brianna Maya suffered a severe life threatening reaction after taking Children's Motrin for a fever and cough. While doctors were able to save her life she was left with lifelong injuries that continue to put her health at risk in the future. "The award is based on...

2011-05-23 13:56:00

MORRISTOWN, N.J., May 23, 2011 /PRNewswire/ -- Bayer HealthCare's Consumer Care division announced today the introduction of Bayer® Advanced Aspirin, the next generation of aspirin for pain relief. Using the patent-pending Pro-Release(TM) Technology, Bayer Advanced Aspirin is clinically proven to relieve tough pain twice as fast as previous Bayer® Aspirin tablets*. To view the multimedia assets associated with this release, go to:...

2011-05-17 07:03:00

SHIRLEY, N.Y. and PARSIPPANY, N.J., May 17, 2011 /PRNewswire/ -- Regency Therapeutics, a newly established division of Luitpold Pharmaceuticals, Inc., and its co-promotion partner Daiichi Sankyo, Inc., announced today that they have launched SPRIX® (ketorolac tromethamine) Nasal Spray and that it is now commercially available. SPRIX® was approved by the U.S. Food and Drug Administration (FDA) in May 2010 for the short-term (up to 5 days) management of...

2011-05-16 05:45:00

NASHVILLE, Tenn., May 16, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced that results from a clinical study evaluating the safety and efficacy of Caldolor® (ibuprofen) Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research. The study demonstrated that Caldolor significantly reduces fever in these patients, including those with severe thermal...

523036d4d2f46bbde13ef3a0dfb5c25e
2011-05-12 12:14:18

The banning of a painkiller that causes visceral gout, a fatal kidney ailment in vultures, has shown first signs of progress in the populations of South Asian vultures, according to scientists. But the study warns that the death rate from the drug is still too high, and that the complete removal of the painkiller, diclofenac, is needed to see further recovery of the wild vulture populations. Veterinary use of diclofenac in the treatment of cattle and buffaloes was banned in 2006 by India,...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related